These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20715976)

  • 21. The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population.
    Wu H; Huang Q; Yu Z; Wu H; Zhong Z
    Lipids Health Dis; 2020 Sep; 19(1):202. PubMed ID: 32891149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS).
    Maitland-van der Zee AH; Jukema JW; Zwinderman AH; Hallman DM; De Boer A; Kastelein JJ; De Knijff P
    Acta Cardiol; 2006 Jun; 61(3):327-31. PubMed ID: 16869455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between lifestyle-related factors and the ApoE polymorphism on plasma lipids and apolipoproteins. The EARS Study. European Atherosclerosis Research Study.
    Boer JM; Ehnholm C; Menzel HJ; Havekes LM; Rosseneu M; O'Reilly DS; Tiret L
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1675-81. PubMed ID: 9327762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examining the effects of the CLU and APOE polymorphisms' combination on coronary artery disease complexed with type 2 diabetes mellitus.
    Ozuynuk AS; Erkan AF; Dogan N; Ekici B; Erginel-Unaltuna N; Kurmus O; Coban N
    J Diabetes Complications; 2022 Jan; 36(1):108078. PubMed ID: 34686405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The independent correlation of the impact of lipoprotein(a) levels and apolipoprotein E polymorphism on carotid artery intima thickness.
    Horejsí B; Spácil J; Ceska R; Vrablík M; Haas T; Horínek A
    Int Angiol; 2000 Dec; 19(4):331-6. PubMed ID: 11305732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass-spectrometric analysis of APOB polymorphism rs1042031 (G/T) and its influence on serum proteome of coronary artery disease patients: genetic-derived proteomics consequences.
    Zafar M; Malik IR; Mirza MR; Awan FR; Nawrocki A; Hussain M; Khan HN; Abbas S; Choudhary MI; Larsen MR
    Mol Cell Biochem; 2024 Jun; 479(6):1349-1361. PubMed ID: 37410210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of apolipoprotein E genotypes with serum lipid profiles in a healthy population of Taiwan.
    Lin SK; Kao JT; Tsai SM; Tsai LY; Lin MN; Lai CJ; Zhong WL
    Ann Clin Lab Sci; 2004; 34(4):443-8. PubMed ID: 15648787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between gene polymorphism at the apolipoprotein E locus and serum lipid profile in urban children of school age in Beijing].
    Zhu W; Feng N; Wang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):297-300. PubMed ID: 11769625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of serum apolipoprotein E concentration and polymorphism on serum lipid parameters in hemodialysis patients.
    Liberopoulos EN; Miltiadous GA; Cariolou M; Tselepis AD; Siamopoulos KC; Elisaf MS
    Am J Kidney Dis; 2004 Aug; 44(2):300-8. PubMed ID: 15264189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease.
    Rai TS; Khullar M; Sehrawat BS; Ahuja M; Sharma PK; Vijayvergiya R; Grover A
    Mol Cell Biochem; 2008 Jun; 313(1-2):139-46. PubMed ID: 18398670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of apolipoprotein E gene polymorphism with end-stage renal disease and hyperlipidemia in patients on long-term hemodialysis.
    Lahrach H; Essiarab F; Timinouni M; Hatim B; El Khayat S; Er-Rachdi L; Jarir J; Kettani A; Ghalim N; Taki H; Lebrazi H; Ramdani B; Saïle R
    Ren Fail; 2014 Nov; 36(10):1504-9. PubMed ID: 25155022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The APOE E4 Allele Confers Increased Risk of Ischemic Stroke Among Greek Carriers.
    Konialis C; Spengos K; Iliopoulos P; Karapanou S; Gialafos E; Hagnefelt B; Vemmos K; Zakopoulos N; Pangalos C
    Adv Clin Exp Med; 2016; 25(3):471-8. PubMed ID: 27629735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E polymorphisms in Mexican patients with coronary artery disease.
    Gamboa R; Huesca-Gómez C; Pérez-Méndez O; Cruz-Robles D; Fragoso JM; Juarez-Cedillo T; Vallejo M; Posadas-Romero C; Vargas-Alarcón G
    Clin Chem Lab Med; 2008; 46(4):481-5. PubMed ID: 18298348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.
    Tascilar N; Dursun A; Ankarali H; Mungan G; Sumbuloglu V; Ekem S; Bozdogan S; Baris S; Aciman E; Cabuk F
    J Neurol Sci; 2009 Feb; 277(1-2):17-21. PubMed ID: 18945448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between apolipoprotein E gene polymorphism and the risk of coronary artery disease in Hakka postmenopausal women in southern China.
    Hou J; Deng Q; Guo X; Deng X; Zhong W; Zhong Z
    Lipids Health Dis; 2020 Jun; 19(1):139. PubMed ID: 32546237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE polymorphism is associated with blood lipid and serum uric acid metabolism in hypertension or coronary heart disease in a Chinese population.
    Wang C; Yan W; Wang H; Zhu J; Chen H
    Pharmacogenomics; 2019 Sep; 20(14):1021-1031. PubMed ID: 31559922
    [No Abstract]   [Full Text] [Related]  

  • 37. Apolipoprotein E polymorphism in Omani dyslipidemic patients with and without coronary artery disease.
    Al-Yahyaee SA; Ganguly SS; Al Kindi MN; Al-Bahrani AI
    Hum Biol; 2007 Feb; 79(1):93-102. PubMed ID: 17985658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of polymorphisms at restriction enzyme recognition sites of apolipoprotein B and E gene with dyslipidemia in children undergoing primary nephrotic syndrome.
    Hu P; Qin YH; Jing CX; Lei FY; Chen P; Li MF
    Mol Biol Rep; 2009 May; 36(5):1015-21. PubMed ID: 18512131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.
    Gungor Z; Anuurad E; Enkhmaa B; Zhang W; Kim K; Berglund L
    Atherosclerosis; 2012 Jul; 223(1):230-4. PubMed ID: 22632920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease.
    Aydogan HY; Isbir S; Kurnaz O; Gormus U; Isbir T
    In Vivo; 2009; 23(1):155-61. PubMed ID: 19368142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.